Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients

This study has been completed.
Eli Lilly and Company
Information provided by (Responsible Party):
Dr. Roumen Milev, Queen's University Identifier:
First received: August 22, 2007
Last updated: December 14, 2015
Last verified: December 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):